Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystic Fibrosis | 20 | 2024 | 1285 | 3.960 |
Why?
|
Systemic Inflammatory Response Syndrome | 14 | 2024 | 621 | 2.870 |
Why?
|
Myocarditis | 3 | 2023 | 788 | 1.450 |
Why?
|
Lung Diseases | 4 | 2020 | 1909 | 1.240 |
Why?
|
Pseudomonas aeruginosa | 9 | 2024 | 1277 | 1.210 |
Why?
|
Neutrophils | 9 | 2022 | 3767 | 1.200 |
Why?
|
Respiratory Mucosa | 3 | 2024 | 439 | 1.090 |
Why?
|
Transendothelial and Transepithelial Migration | 4 | 2017 | 100 | 0.940 |
Why?
|
Antibodies, Viral | 12 | 2024 | 3156 | 0.820 |
Why?
|
Pseudomonas Infections | 4 | 2024 | 622 | 0.800 |
Why?
|
Connective Tissue Diseases | 2 | 2023 | 285 | 0.790 |
Why?
|
Lung Transplantation | 2 | 2020 | 1310 | 0.720 |
Why?
|
Haptoglobins | 1 | 2021 | 166 | 0.690 |
Why?
|
Endocannabinoids | 1 | 2021 | 111 | 0.690 |
Why?
|
Child | 35 | 2024 | 80156 | 0.660 |
Why?
|
Eicosanoids | 1 | 2021 | 282 | 0.640 |
Why?
|
Specimen Handling | 2 | 2020 | 702 | 0.640 |
Why?
|
Glycogen Storage Disease | 1 | 2018 | 41 | 0.630 |
Why?
|
Coculture Techniques | 4 | 2022 | 1341 | 0.610 |
Why?
|
Antigens, Human Platelet | 1 | 2017 | 41 | 0.580 |
Why?
|
Referral and Consultation | 2 | 2020 | 3600 | 0.560 |
Why?
|
Protein Precursors | 1 | 2021 | 1132 | 0.560 |
Why?
|
Advance Directives | 1 | 2018 | 249 | 0.550 |
Why?
|
Viral Load | 3 | 2021 | 3332 | 0.520 |
Why?
|
Pregnancy Complications, Infectious | 6 | 2024 | 2151 | 0.510 |
Why?
|
Adaptive Immunity | 3 | 2021 | 726 | 0.500 |
Why?
|
Patient Preference | 2 | 2020 | 924 | 0.470 |
Why?
|
DNA Transposable Elements | 1 | 2018 | 755 | 0.460 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3086 | 0.460 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3206 | 0.460 |
Why?
|
Mutagenesis | 1 | 2018 | 1232 | 0.450 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 4 | 2024 | 450 | 0.450 |
Why?
|
Palliative Care | 4 | 2024 | 3598 | 0.430 |
Why?
|
8,11,14-Eicosatrienoic Acid | 3 | 2017 | 64 | 0.410 |
Why?
|
Humans | 80 | 2024 | 761572 | 0.400 |
Why?
|
Bronchoscopes | 1 | 2012 | 64 | 0.390 |
Why?
|
Leukotriene B4 | 3 | 2017 | 280 | 0.380 |
Why?
|
Advance Care Planning | 1 | 2018 | 699 | 0.370 |
Why?
|
Pulmonary Aspergillosis | 1 | 2011 | 47 | 0.370 |
Why?
|
Respiratory Insufficiency | 1 | 2019 | 1230 | 0.370 |
Why?
|
Bronchoscopy | 2 | 2018 | 909 | 0.360 |
Why?
|
Infant | 12 | 2024 | 36192 | 0.360 |
Why?
|
Child, Preschool | 12 | 2024 | 42230 | 0.360 |
Why?
|
Respiratory System Abnormalities | 1 | 2011 | 67 | 0.360 |
Why?
|
Fiber Optic Technology | 1 | 2012 | 290 | 0.350 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3032 | 0.350 |
Why?
|
Pandemics | 9 | 2023 | 8656 | 0.350 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1667 | 0.340 |
Why?
|
Lung Diseases, Interstitial | 1 | 2018 | 918 | 0.340 |
Why?
|
Immunity, Humoral | 2 | 2024 | 606 | 0.320 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1642 | 0.320 |
Why?
|
Hypertension, Pulmonary | 1 | 2020 | 1578 | 0.320 |
Why?
|
Lung | 5 | 2022 | 10002 | 0.320 |
Why?
|
Airway Management | 1 | 2012 | 312 | 0.310 |
Why?
|
Monocytes | 3 | 2022 | 2570 | 0.300 |
Why?
|
Infant, Newborn | 12 | 2022 | 26198 | 0.300 |
Why?
|
Antibody Formation | 2 | 2022 | 1395 | 0.300 |
Why?
|
Inflammation | 8 | 2022 | 10773 | 0.300 |
Why?
|
Quality of Life | 4 | 2024 | 13367 | 0.290 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3249 | 0.280 |
Why?
|
Respiratory Tract Infections | 1 | 2015 | 1010 | 0.280 |
Why?
|
Genetic Testing | 1 | 2020 | 3537 | 0.280 |
Why?
|
Young Adult | 12 | 2024 | 59255 | 0.270 |
Why?
|
Adolescent | 16 | 2023 | 88324 | 0.270 |
Why?
|
Terminal Care | 1 | 2018 | 1761 | 0.270 |
Why?
|
Neutrophil Infiltration | 3 | 2017 | 390 | 0.270 |
Why?
|
Staphylococcus aureus | 3 | 2024 | 1457 | 0.260 |
Why?
|
Benzodioxoles | 2 | 2023 | 75 | 0.260 |
Why?
|
Aminophenols | 2 | 2023 | 87 | 0.260 |
Why?
|
Vaccination | 5 | 2024 | 3384 | 0.250 |
Why?
|
Tomography, Optical Coherence | 4 | 2021 | 2917 | 0.250 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4016 | 0.250 |
Why?
|
Placenta | 4 | 2022 | 1709 | 0.240 |
Why?
|
Phenazines | 1 | 2024 | 56 | 0.230 |
Why?
|
Immunoglobulin G | 5 | 2023 | 4544 | 0.230 |
Why?
|
Cytokines | 3 | 2024 | 7396 | 0.230 |
Why?
|
Hyperglycemia | 2 | 2024 | 1376 | 0.230 |
Why?
|
Massachusetts | 3 | 2022 | 8830 | 0.220 |
Why?
|
Epithelium | 2 | 2019 | 1603 | 0.220 |
Why?
|
Epithelial Cells | 3 | 2022 | 3677 | 0.220 |
Why?
|
Opiate Alkaloids | 1 | 2023 | 28 | 0.210 |
Why?
|
Cell Movement | 3 | 2021 | 5205 | 0.210 |
Why?
|
Immunity | 4 | 2022 | 996 | 0.210 |
Why?
|
Microbial Sensitivity Tests | 3 | 2024 | 1937 | 0.210 |
Why?
|
Health Promotion | 1 | 2015 | 2214 | 0.210 |
Why?
|
Immunoglobulin A | 2 | 2023 | 978 | 0.200 |
Why?
|
Primary Health Care | 1 | 2019 | 4686 | 0.200 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5672 | 0.190 |
Why?
|
Anti-Bacterial Agents | 5 | 2024 | 7407 | 0.180 |
Why?
|
Complementarity Determining Regions | 1 | 2021 | 149 | 0.180 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 111 | 0.180 |
Why?
|
Quinolones | 1 | 2023 | 378 | 0.170 |
Why?
|
Adult | 22 | 2024 | 221203 | 0.170 |
Why?
|
Chemotaxis, Leukocyte | 3 | 2017 | 662 | 0.170 |
Why?
|
Lymphopenia | 1 | 2022 | 281 | 0.170 |
Why?
|
Pepsin A | 1 | 2019 | 66 | 0.170 |
Why?
|
Bile | 1 | 2020 | 298 | 0.170 |
Why?
|
DNA | 1 | 2013 | 7213 | 0.170 |
Why?
|
Gastric Acid | 1 | 2019 | 99 | 0.170 |
Why?
|
Permeability | 1 | 2021 | 723 | 0.160 |
Why?
|
Forced Expiratory Volume | 2 | 2023 | 1814 | 0.160 |
Why?
|
Nuclear Proteins | 1 | 2013 | 5799 | 0.160 |
Why?
|
Aspergillus fumigatus | 1 | 2020 | 157 | 0.160 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 461 | 0.150 |
Why?
|
Female | 30 | 2024 | 392686 | 0.150 |
Why?
|
Aspergillosis | 1 | 2020 | 242 | 0.150 |
Why?
|
Candida albicans | 1 | 2021 | 372 | 0.150 |
Why?
|
Tobramycin | 1 | 2017 | 65 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 799 | 0.140 |
Why?
|
Antigens, Viral | 1 | 2021 | 988 | 0.140 |
Why?
|
Fumarates | 1 | 2017 | 131 | 0.140 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 1351 | 0.140 |
Why?
|
Bacteria | 2 | 2020 | 2199 | 0.140 |
Why?
|
New England | 1 | 2020 | 1054 | 0.140 |
Why?
|
Cell Wall | 1 | 2020 | 425 | 0.140 |
Why?
|
Pediatrics | 3 | 2020 | 3589 | 0.140 |
Why?
|
Virus Internalization | 1 | 2020 | 497 | 0.140 |
Why?
|
Cell Line | 4 | 2019 | 15601 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17904 | 0.130 |
Why?
|
RNA, Messenger | 4 | 2024 | 12794 | 0.130 |
Why?
|
Male | 20 | 2024 | 360842 | 0.130 |
Why?
|
Drug Resistance, Bacterial | 2 | 2020 | 1048 | 0.130 |
Why?
|
Pulmonary Alveoli | 1 | 2018 | 652 | 0.130 |
Why?
|
Oligopeptides | 1 | 2021 | 1187 | 0.130 |
Why?
|
Age Factors | 2 | 2024 | 18398 | 0.130 |
Why?
|
Nose | 1 | 2019 | 521 | 0.130 |
Why?
|
Mutagenesis, Insertional | 1 | 2018 | 656 | 0.130 |
Why?
|
Indoles | 1 | 2023 | 1833 | 0.120 |
Why?
|
Phagocytosis | 1 | 2021 | 1528 | 0.120 |
Why?
|
Fetal Development | 1 | 2020 | 769 | 0.120 |
Why?
|
Staphylococcal Infections | 1 | 2024 | 1407 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1349 | 0.120 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2021 | 803 | 0.120 |
Why?
|
Chemotaxis | 1 | 2017 | 598 | 0.120 |
Why?
|
Cytosol | 1 | 2017 | 888 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 22173 | 0.110 |
Why?
|
Cell Polarity | 1 | 2017 | 636 | 0.110 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 935 | 0.110 |
Why?
|
Autoantibodies | 1 | 2023 | 2116 | 0.110 |
Why?
|
Fetal Blood | 1 | 2020 | 1347 | 0.110 |
Why?
|
Peroxidase | 1 | 2017 | 609 | 0.110 |
Why?
|
Transcription Factors | 1 | 2013 | 12129 | 0.110 |
Why?
|
Autoimmunity | 1 | 2021 | 1356 | 0.110 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2468 | 0.110 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26127 | 0.100 |
Why?
|
Bacterial Proteins | 3 | 2024 | 3847 | 0.100 |
Why?
|
Acute Disease | 1 | 2023 | 7237 | 0.100 |
Why?
|
Rhinitis | 1 | 2020 | 747 | 0.100 |
Why?
|
Nanoparticles | 1 | 2024 | 1959 | 0.100 |
Why?
|
Biofilms | 3 | 2024 | 628 | 0.100 |
Why?
|
Cost of Illness | 2 | 2023 | 1936 | 0.100 |
Why?
|
Immunity, Innate | 2 | 2022 | 3066 | 0.100 |
Why?
|
Pregnancy | 9 | 2024 | 29876 | 0.100 |
Why?
|
Patient Participation | 1 | 2020 | 1445 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1809 | 0.090 |
Why?
|
Case-Control Studies | 4 | 2021 | 22176 | 0.090 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 2629 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4580 | 0.090 |
Why?
|
Sinusitis | 1 | 2020 | 991 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15843 | 0.090 |
Why?
|
Mutation | 2 | 2023 | 30054 | 0.090 |
Why?
|
Consensus | 1 | 2020 | 3123 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2021 | 2747 | 0.090 |
Why?
|
Cell Communication | 1 | 2017 | 1657 | 0.090 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2024 | 467 | 0.080 |
Why?
|
Lactation | 2 | 2022 | 397 | 0.080 |
Why?
|
Depression | 2 | 2019 | 8124 | 0.080 |
Why?
|
Influenza A virus | 2 | 2022 | 458 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2023 | 10194 | 0.070 |
Why?
|
Membrane Transport Proteins | 2 | 2024 | 1035 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3204 | 0.070 |
Why?
|
Biopsy | 1 | 2018 | 6766 | 0.070 |
Why?
|
Substance-Related Disorders | 1 | 2023 | 4420 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4063 | 0.060 |
Why?
|
Comorbidity | 1 | 2020 | 10508 | 0.060 |
Why?
|
Pilot Projects | 1 | 2019 | 8633 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5841 | 0.060 |
Why?
|
Virulence | 2 | 2020 | 1303 | 0.060 |
Why?
|
Sexual Behavior | 1 | 2015 | 2180 | 0.060 |
Why?
|
Animals | 5 | 2021 | 168467 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3250 | 0.060 |
Why?
|
Pyocyanine | 1 | 2024 | 20 | 0.060 |
Why?
|
Asthma | 1 | 2023 | 6234 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3511 | 0.060 |
Why?
|
Tetracycline | 1 | 2024 | 216 | 0.060 |
Why?
|
Carboxylic Acids | 1 | 2024 | 90 | 0.060 |
Why?
|
RNA, Viral | 2 | 2023 | 2846 | 0.060 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2024 | 105 | 0.050 |
Why?
|
Health Behavior | 1 | 2015 | 2644 | 0.050 |
Why?
|
Sulfates | 1 | 2024 | 380 | 0.050 |
Why?
|
Conscious Sedation | 1 | 2007 | 532 | 0.050 |
Why?
|
Antibodies, Neutralizing | 2 | 2023 | 1943 | 0.050 |
Why?
|
Alginates | 1 | 2024 | 248 | 0.050 |
Why?
|
Retinopathy of Prematurity | 1 | 2007 | 439 | 0.050 |
Why?
|
United States | 4 | 2023 | 72335 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4573 | 0.050 |
Why?
|
Cohort Studies | 5 | 2023 | 41493 | 0.050 |
Why?
|
Fomites | 1 | 2021 | 15 | 0.050 |
Why?
|
Aging | 1 | 2020 | 8711 | 0.050 |
Why?
|
Polysaccharides, Bacterial | 1 | 2024 | 578 | 0.050 |
Why?
|
Neutrophil Activation | 1 | 2021 | 180 | 0.050 |
Why?
|
Nasal Lavage | 1 | 2020 | 17 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10721 | 0.040 |
Why?
|
Communication | 1 | 2015 | 3873 | 0.040 |
Why?
|
Laser Therapy | 1 | 2007 | 1092 | 0.040 |
Why?
|
Naphthols | 1 | 2020 | 46 | 0.040 |
Why?
|
Chlorides | 1 | 2023 | 665 | 0.040 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 131 | 0.040 |
Why?
|
Spores, Fungal | 1 | 2020 | 90 | 0.040 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2024 | 587 | 0.040 |
Why?
|
Spirometry | 1 | 2023 | 929 | 0.040 |
Why?
|
Mucociliary Clearance | 1 | 2019 | 80 | 0.040 |
Why?
|
Ebolavirus | 1 | 2022 | 251 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 535 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2021 | 545 | 0.040 |
Why?
|
Middle Aged | 4 | 2024 | 220920 | 0.040 |
Why?
|
Blood Glucose | 2 | 2024 | 6391 | 0.040 |
Why?
|
Aerosols | 1 | 2021 | 635 | 0.040 |
Why?
|
Esophageal pH Monitoring | 1 | 2019 | 202 | 0.040 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2024 | 1133 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 1 | 2020 | 583 | 0.040 |
Why?
|
Quinolines | 1 | 2023 | 764 | 0.040 |
Why?
|
Perinatal Care | 1 | 2020 | 243 | 0.040 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 221 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12148 | 0.040 |
Why?
|
Melanins | 1 | 2020 | 290 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2024 | 1844 | 0.040 |
Why?
|
Needs Assessment | 1 | 2023 | 1139 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2020 | 559 | 0.040 |
Why?
|
Species Specificity | 1 | 2022 | 2414 | 0.040 |
Why?
|
Mucus | 1 | 2019 | 341 | 0.040 |
Why?
|
Granulocytes | 1 | 2019 | 551 | 0.040 |
Why?
|
Drug Combinations | 1 | 2023 | 2048 | 0.040 |
Why?
|
Risk Factors | 1 | 2024 | 74213 | 0.040 |
Why?
|
Bile Acids and Salts | 1 | 2019 | 393 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 523 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 6935 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2022 | 823 | 0.030 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 536 | 0.030 |
Why?
|
Azithromycin | 1 | 2017 | 199 | 0.030 |
Why?
|
Disease Progression | 2 | 2023 | 13510 | 0.030 |
Why?
|
Mice | 3 | 2017 | 81533 | 0.030 |
Why?
|
Immunoglobulin M | 1 | 2020 | 1526 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2023 | 1403 | 0.030 |
Why?
|
Outpatients | 1 | 2023 | 1597 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1023 | 0.030 |
Why?
|
Sputum | 1 | 2017 | 506 | 0.030 |
Why?
|
Cilia | 1 | 2019 | 495 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2496 | 0.030 |
Why?
|
Receptors, Leukotriene B4 | 1 | 2014 | 92 | 0.030 |
Why?
|
Viral Proteins | 1 | 2022 | 1804 | 0.030 |
Why?
|
Psychometrics | 1 | 2024 | 3065 | 0.030 |
Why?
|
Proton Pump Inhibitors | 1 | 2019 | 532 | 0.030 |
Why?
|
Intestine, Small | 1 | 2020 | 1206 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54426 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2022 | 1802 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3306 | 0.030 |
Why?
|
Patient Care Management | 1 | 2017 | 302 | 0.030 |
Why?
|
Infection Control | 1 | 2021 | 982 | 0.030 |
Why?
|
Models, Organizational | 1 | 2017 | 546 | 0.030 |
Why?
|
Esophagus | 1 | 2019 | 1033 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58986 | 0.030 |
Why?
|
Pyrazoles | 1 | 2023 | 2009 | 0.030 |
Why?
|
Otolaryngology | 1 | 2020 | 693 | 0.030 |
Why?
|
Aged | 3 | 2021 | 169310 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2019 | 819 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4369 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2448 | 0.020 |
Why?
|
Pyridines | 1 | 2023 | 2875 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2023 | 3060 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3088 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2014 | 733 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1612 | 0.020 |
Why?
|
Blotting, Western | 1 | 2017 | 5035 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12341 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4758 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4244 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20571 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3848 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6312 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14607 | 0.020 |
Why?
|
Bacterial Infections | 1 | 2014 | 1391 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20099 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9420 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9319 | 0.020 |
Why?
|
Smoking | 1 | 2021 | 9053 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 16986 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18965 | 0.010 |
Why?
|
Time Factors | 1 | 2022 | 39970 | 0.010 |
Why?
|
Intubation, Intratracheal | 1 | 2007 | 1333 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22172 | 0.010 |
Why?
|
Respiration, Artificial | 1 | 2007 | 2630 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18253 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 80646 | 0.010 |
Why?
|